MX2022014731A - Extracto que contiene oleandrina y metodo de produccion de este. - Google Patents

Extracto que contiene oleandrina y metodo de produccion de este.

Info

Publication number
MX2022014731A
MX2022014731A MX2022014731A MX2022014731A MX2022014731A MX 2022014731 A MX2022014731 A MX 2022014731A MX 2022014731 A MX2022014731 A MX 2022014731A MX 2022014731 A MX2022014731 A MX 2022014731A MX 2022014731 A MX2022014731 A MX 2022014731A
Authority
MX
Mexico
Prior art keywords
oleandrin
production
extract
extract containing
methods
Prior art date
Application number
MX2022014731A
Other languages
English (en)
Spanish (es)
Inventor
Otis C Addington
Robert A Newman
Richard J Obiso
Original Assignee
Phoenix Biotechnology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US16/895,920 external-priority patent/US10729735B1/en
Priority claimed from PCT/US2020/042009 external-priority patent/WO2021201903A1/en
Priority claimed from PCT/US2021/022800 external-priority patent/WO2021202103A2/en
Application filed by Phoenix Biotechnology Inc filed Critical Phoenix Biotechnology Inc
Publication of MX2022014731A publication Critical patent/MX2022014731A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/24—Apocynaceae (Dogbane family), e.g. plumeria or periwinkle
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/30—Other Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/37—Extraction at elevated pressure or temperature, e.g. pressurized solvent extraction [PSE], supercritical carbon dioxide extraction or subcritical water extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/805—Corresponding aspects not provided for by any of codes A61K2800/81 - A61K2800/95

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Birds (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Polymers & Plastics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Compounds Of Unknown Constitution (AREA)
MX2022014731A 2020-05-24 2021-05-19 Extracto que contiene oleandrina y metodo de produccion de este. MX2022014731A (es)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US202063029530P 2020-05-24 2020-05-24
US202063034800P 2020-06-04 2020-06-04
US16/895,920 US10729735B1 (en) 2016-09-14 2020-06-08 Method and compostitions for treating coronavirus infection
US202063042656P 2020-06-23 2020-06-23
US202063051576P 2020-07-14 2020-07-14
PCT/US2020/042009 WO2021201903A1 (en) 2020-03-31 2020-07-14 Method and compositions for treating coronavirus infection
US202063057727P 2020-07-28 2020-07-28
US202063059776P 2020-07-31 2020-07-31
US202163159242P 2021-03-10 2021-03-10
PCT/US2021/022800 WO2021202103A2 (en) 2020-03-31 2021-03-17 Method and compositions for treating coronavirus infection
PCT/US2021/033176 WO2021242590A1 (en) 2020-05-24 2021-05-19 Extract containing oleandrin and method of production thereof

Publications (1)

Publication Number Publication Date
MX2022014731A true MX2022014731A (es) 2023-02-27

Family

ID=78722716

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022014731A MX2022014731A (es) 2020-05-24 2021-05-19 Extracto que contiene oleandrina y metodo de produccion de este.

Country Status (8)

Country Link
EP (1) EP4156947A4 (de)
JP (1) JP7648195B2 (de)
KR (1) KR20230016196A (de)
CN (1) CN116322339A (de)
AU (1) AU2021282086A1 (de)
CA (1) CA3180022A1 (de)
MX (1) MX2022014731A (de)
WO (1) WO2021242590A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112689510B (zh) * 2020-03-31 2022-02-01 菲尼克斯生物技术公司 用于治疗冠状病毒感染的方法和组合物
CN114668773B (zh) * 2022-04-08 2023-10-03 山东中医药大学 重楼提取物在抗克里米亚刚果出血热病毒中的应用
KR102704483B1 (ko) * 2023-02-28 2024-09-10 대한민국(질병관리청 국립보건연구원장) 스테로이드 유도체 계열 화합물 및 이를 유효성분으로 함유하는 항바이러스제
CN118319830B (zh) * 2024-04-22 2025-01-28 广州博科化妆品有限公司 一种紧致皮肤抗皱精华液及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060205679A1 (en) * 2004-10-22 2006-09-14 Azaya Therapeutics, Inc. Topical and oral formulations of cardiac glycosides for treating skin diseases
US7402325B2 (en) * 2005-07-28 2008-07-22 Phoenix Biotechnology, Inc. Supercritical carbon dioxide extract of pharmacologically active components from Nerium oleander
BR112012017073A2 (pt) * 2010-01-11 2015-09-01 Phoenix Biotechnology Inc Método de tratamento de condições neurológicas com glicosídeos cardíacos
MX345675B (es) 2010-11-22 2017-02-10 Phoenix Biotechnology Inc Metodo para tratar condiciones neurologicas con extracto de especie nerium o especie thevetia.
WO2012129683A1 (en) 2011-03-25 2012-10-04 Biopharmacopae Design International Inc. Extracts from plants of the tsuga genus and uses thereof in the treatment of skin disorders
EP3475402B1 (de) * 2016-06-24 2023-08-02 Cool Clean Technologies, LLC Verfahren zur extraktion von cannabinoiden mittels flüssigem kohlendioxid
US10702567B2 (en) 2016-09-14 2020-07-07 Phoenix Biotechnology, Inc. Method and compositions for treating viral infection
KR20180060726A (ko) * 2016-11-29 2018-06-07 주식회사 엘지생활건강 올레안드린을 포함하는 화장료 조성물
SG11202105728YA (en) 2020-03-31 2021-11-29 Phoenix Biotechnology Inc Method and compositions for treating coronavirus infection
EP4295854A3 (de) * 2020-03-31 2024-04-03 Phoenix Biotechnology, Inc. Verfahren und zusammensetzungen zur behandlung von coronavirusinfektionen

Also Published As

Publication number Publication date
AU2021282086A1 (en) 2023-01-05
CN116322339A (zh) 2023-06-23
KR20230016196A (ko) 2023-02-01
WO2021242590A1 (en) 2021-12-02
CA3180022A1 (en) 2021-12-02
JP7648195B2 (ja) 2025-03-18
JP2023527979A (ja) 2023-07-03
EP4156947A4 (de) 2024-08-14
EP4156947A1 (de) 2023-04-05

Similar Documents

Publication Publication Date Title
MX2022014731A (es) Extracto que contiene oleandrina y metodo de produccion de este.
RU2014151157A (ru) Применение композиции для получения изделий медицинского назначения или лекарственных средств для профилактики и лечения аллергических заболеваний
CN104232314A (zh) 桔梗籽精油的制备方法和桔梗籽精油保健品
CN103880913B (zh) 一种具有保肝作用的化合物及其应用
CN104771456B (zh) 拳参提取物在抑制酪氨酸酶活性中的应用
CN102716169B (zh) 川木香或其提取物在制备治疗慢性萎缩性胃炎的药物中的用途
CN104586837B (zh) 灰毛浆果楝a及其类似物在制备抗抑郁症药物中的用途
CN106860771B (zh) 一种天麻精制组分的制备方法及天麻精制组分和应用
CN103923156B (zh) 具有保肝作用的皂苷化合物及其应用
CN109223739A (zh) 一种组合物及其制备方法和应用
WO2020165614A9 (en) Method for obtaining oleocanthal type secoiridoids and for producing respective pharmaceutical preparations
CN104083390A (zh) 6，7-二羟基-5-β-D-吡喃葡萄糖-4`-β-O-D-吡喃葡萄糖黄酮在制备抗炎药物中的用途
RU2139724C1 (ru) Способ получения экстракта из обезжиренных плодов расторопши пятнистой
EA201500621A1 (ru) Способ получения мангиферина
Kumar et al. Antidepressant potential of isolated bioactive compound from Butea monosperma (Lam.) kuntze
CN103387580A (zh) 百部生物碱单体成分及其用途
CN104758335A (zh) 一种具有抗炎活性的山风乙酸乙酯提取物的制备方法及其应用
CN105193877A (zh) 一种神秘果树枝提取物及其在制备具有降血糖或降血脂作用的药物或保健品中的应用
CN101095700A (zh) 发酵虫草菌粉活性部位的制备方法及其在呼吸道疾病方面的应用
TWI394576B (zh) 以人參、大棗為原料的治療憂鬱症的藥物組合物及其製法
CN105311070A (zh) 一种神秘果果核及其提取物在制备具有止痛作用的药物或保健品中的应用
EA051251B1 (ru) Способ получения лекарственного средства, обладающего гипотензивным и седативным действием, из надземной части шлемника восточного
CN107721871B (zh) 一种分子蒸馏分离纯化魔芋神经酰胺的方法
Lerner et al. Use of achyranthes in the treatment of urolithiasis
CN104529733B (zh) 一种高良姜中分离的单体及其用于抗肿瘤用途